Device evaluation summary: the reported failing blood tests, was verified during service.The service technician stated that one channel would randomly stop extremely early.During the service the customer stated there was a 50% failure rate on human blood samples.The customer did not check the cartridge to see if it was actual coagulation or another issue and they stated that if a sample failed they immediately threw it away.The service technician stated that the lift wire stepper motor was bad and it was not parking in same position each time.The issue was resolved by replacing flag motor.The service technician stated that they observed other issues with client sampling such as the client contaminating the sidewall of the cartridge above the fill line, bending the flag on the cartridge with a finger to insert the needle into the cartridge and allowing excess bubbles into the sample.The service technician showed the customer the appropriate techniques for gathering a sample in the cartridge.Preventive maintenance was performed as per specification.Conclusion: complaint is confirmed for the act plus instruments reportedly failing blood tests.No patient/clinical safety issues re ported.Trends for issues with this product are reviewed at quarterly quality meetings.This regulatory report is being submitted as part of a retrospective review and remediation per d00953163 as part of a capa action.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|